Vem Pharmaceuticals
VEM İLAÇ is a pharmaceutical company with over 20 years of experience, serving both domestic and international markets. The company specializes in a wide range of medical products used in various treatment fields such as nephrology, pulmonology, gastroenterology, pediatrics, urology, dermatology, ophthalmology, oncology, cardiology, vascular surgery, intensive care, and anesthesia. Committed to high quality and technological advancement, VEM İLAÇ aims to improve the healthcare sector with its innovative and reliable products, contributing to a healthier future. The company actively participates in educational events, international collaborations, and industry symposiums, emphasizing its commitment to innovation, quality, and social responsibility.
Industries
Nr. of Employees
large (251-1000)
Vem Pharmaceuticals
Products
Respiratory system medicines
Pharmaceutical products for diagnosis and treatment of respiratory conditions.
Infectious disease medicines
Antibacterial, antiviral and other anti-infective pharmaceutical products.
Cardiovascular system medicines
Medicines for cardiovascular diseases and related surgical care.
Central nervous system medicines
Medicinal products for disorders of the central nervous system.
Anesthesia medicines
Pharmaceuticals used in anesthesia and intensive care.
Ophthalmology medicines
Eye care pharmaceuticals including preservative-free and cold-chain-independent formulations.
Respiratory system medicines
Pharmaceutical products for diagnosis and treatment of respiratory conditions.
Infectious disease medicines
Antibacterial, antiviral and other anti-infective pharmaceutical products.
Cardiovascular system medicines
Medicines for cardiovascular diseases and related surgical care.
Central nervous system medicines
Medicinal products for disorders of the central nervous system.
Anesthesia medicines
Pharmaceuticals used in anesthesia and intensive care.
Ophthalmology medicines
Eye care pharmaceuticals including preservative-free and cold-chain-independent formulations.
Services
Support for entering and developing international markets through trade show participation and partner development.
Commercial business development including establishing licensing, distribution and partnership agreements.
Organization, sponsorship and participation in clinical education activities, satellite symposia and scientific meetings for healthcare professionals.
Support for entering and developing international markets through trade show participation and partner development.
Commercial business development including establishing licensing, distribution and partnership agreements.
Organization, sponsorship and participation in clinical education activities, satellite symposia and scientific meetings for healthcare professionals.
Expertise Areas
- Pharmaceutical manufacturing
- Ophthalmic product formulation and relaunch
- Regulatory compliance for pharmaceuticals (Turkey)
- Quality assurance and quality management
Key Technologies
- Ophthalmic preservative-free multi-dose formulation
- Cold-chain-independent formulation technology
- Pharmaceutical packaging and accessible labeling (Braille/embossing)
- Quality management systems for medicinal products
News & Updates
VEM İLAÇ actively participates in international pharmaceutical fairs such as CPHI in Madrid and Barcelona, and industry symposiums like AHEF Bahar Akademisi, showcasing its innovative products and social responsibility initiatives.
VEM İLAÇ's involvement in industry symposiums such as AHEF Bahar Akademisi and Koç University Food Allergy Symposium, emphasizing its commitment to education, innovation, and social responsibility.
VEM İLAÇ has undertaken initiatives such as changing drug packaging for visually impaired individuals with Braille and participating in social responsibility projects to improve patient access and safety.
VEM İLAÇ announced its 2021 ophthalmology projects, including the launch of preservative-free Brimonidine multi-dose and Latanoprost OTC Plus, in OTC Plus magazine.
VEM İLAÇ participated in the CPHI Barcelona 2016 and Madrid 2018 fairs, and industry symposiums like OTC Plus and AHEF Bahar Akademisi, demonstrating its commitment to innovation and social responsibility.
VEM İLAÇ has redesigned drug packaging to include Braille for visually impaired users and participated in symposiums to promote awareness and accessibility.
VEM İLAÇ actively participates in international pharmaceutical fairs such as CPHI in Madrid and Barcelona, and industry symposiums like AHEF Bahar Akademisi, showcasing its innovative products and social responsibility initiatives.
VEM İLAÇ's involvement in industry symposiums such as AHEF Bahar Akademisi and Koç University Food Allergy Symposium, emphasizing its commitment to education, innovation, and social responsibility.
VEM İLAÇ has undertaken initiatives such as changing drug packaging for visually impaired individuals with Braille and participating in social responsibility projects to improve patient access and safety.
VEM İLAÇ announced its 2021 ophthalmology projects, including the launch of preservative-free Brimonidine multi-dose and Latanoprost OTC Plus, in OTC Plus magazine.
VEM İLAÇ participated in the CPHI Barcelona 2016 and Madrid 2018 fairs, and industry symposiums like OTC Plus and AHEF Bahar Akademisi, demonstrating its commitment to innovation and social responsibility.
VEM İLAÇ has redesigned drug packaging to include Braille for visually impaired users and participated in symposiums to promote awareness and accessibility.